Abbvie Inc. vs Corcept Therapeutics Inc.
ABBV vs CORT — side-by-side comparison from reported financials. ABBV leads 7, CORT leads 4 of 11 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Corcept Therapeutics Inc.
CORT · Healthcare
$121.19+2.24%Strong
| Metric | ABBV | CORT |
|---|---|---|
| Price | $276.43 | $121.19 |
| Market cap | $488B | $13.1B |
| Revenue (TTM) | $64.4B | $831M |
| Revenue growth | +1.8% | +23.7% |
| Net margin | 9.8% | 6.6% |
| Free cash flow | $18.2B | $107M |
| Net cash (debt) | ($56.2B) | $366M |
| 1-year price return | +19.8% | +37.2% |
| P/E | 77.4 | 237.4 |
| P/E vs own history (cheap-side %) | 23% | 0% |
| Dividend yield | 2.45% | — |
| Return on equity | 96% | 8% |
| Altman Z-score | 2.33 | 44.76 |
| CV checks passed | 9 of 11 | 8 of 11 |
| Employees | 57,000 | 730 |
Full résumé-style profiles: ABBV CV · CORT CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.